US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
Post a Comment
Post a Comment